Patent · US Active

Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs

US8273371B2 · kind B2 · utility

2Cited by
10References
9Claims
0Family size

Inventors

Key dates

Filing dateJul 6, 2009
Grant dateSep 25, 2012
Priority date
Expiry dateNov 28, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC01B37/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention describes a new class of crystalline silica material having two levels of porosity and structural order. At the first level, building units are nanoslabs of uniform size having zeolite framework. At the second structural level, nanoslabs are assembled, e.g. linked through their corners, edges or faces following patterns imposed by interaction with cationic surfactant or triblock copolymer molecules. After evacuation of these molecules, microporosity is obtained inside the nanoslabs, and a precise mesoporosity between the nanoslabs depending on the tiling pattern of the zeolite nanoslabs, as evidenced by X-ray diffraction. These materials are useful for the fixation of biologically active species, such as poorly soluble drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.